PI
IMGN

Putnam Investments’s Immunogen Inc IMGN Stock Holding History

Putnam Investments’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-75,073
Closed -$1.19M – 1248
2023
Q3 		$1.19M Sell
75,073
-481,934
-87% -$8.01M ﹤0.01% 814
2023
Q2 		$10.5M Sell
557,007
-594,146
-52% -$7.01M 0.02% 300
2023
Q1 		$4.42M Buy
1,151,153
+29,841
+3% +$127K 0.01% 467
2022
Q4 		$5.56M Buy
1,121,312
+90,220
+9% +$489K 0.01% 412
2022
Q3 		$4.93M Buy
1,031,092
+820,722
+390% +$4.33M 0.01% 437
2022
Q2 		$946K Sell
210,370
-2,612
-1% -$11.3K ﹤0.01% 872
2022
Q1 		$1.01M Sell
212,982
-16,178
-7% -$89.6K ﹤0.01% 898
2021
Q4 		$1.7M Buy
+229,160
New +$1.42M ﹤0.01% 792
2018
Q3 		– Sell
-53,605
Closed -$522K – 1164
2018
Q2 		$522K Buy
+53,605
New +$565K ﹤0.01% 937

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Putnam Investments's IMGN Position: Q4 2023 in Review

Putnam Investments sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 75,073 shares — an estimated $1.19M sold.

Putnam Investments first reported a position in IMGN in Q2 2018 and held it in 9 quarters. The position peaked at $10.5M in Q2 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Putnam Investments reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Putnam Investments sold 75,073 Immunogen Inc shares in Q4 2023, an estimated $1.19M.
  • Putnam Investments first reported a position in Immunogen Inc in Q2 2018 and held it in 9 quarters.
  • Putnam Investments's Immunogen Inc position peaked at $10.5M in Q2 2023.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.